The Founder's Guide to

Epidarex Capital

Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.

Explore our founder-friendly guide and choose if you'd like to be connected.
We'll either provide a warm intro or provide you with more suitable alternatives.
Once you're put in touch, we'll provide you with helpful advice. It's 100% free.

Overview

Epidarex Capital is a transatlantic venture capital firm founded to invest in early-stage life science and health technology companies. The firm operates from both the United Kingdom and the United States, focusing on emerging research hubs. Epidarex has recently closed Fund IV, securing $145 million to support its investment activities.

Learn More

Frequently Asked Questions

Does Epidarex Capital lead rounds?

Yes, Epidarex Capital often leads funding rounds, particularly in seed and Series A stages, to help establish strong foundations for their portfolio companies.

What is Epidarex Capital's stance on follow-on investments?

The firm actively considers follow-on investments to support the growth of its portfolio companies, especially those demonstrating significant progress and potential.

How large is Epidarex Capital's current fund?

Epidarex Capital recently closed Fund IV with $145 million, which will be used to support the next wave of life science startups.

All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.